|
| Exchange Disseminated Time | Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2015, to consider the following :
1. Approval of the unaudited financial Results for the quarter ending March, 2015 along with Audited Annual Accounts for the year 2014-2015.
2. Approval of increase of equity investment percentage in the Company to 49% to Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors etc.
3. Further issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc.
4. Merger of Natco Organics Limited(100% subsidiary Company) into Natco Pharma Limited
5. Consideration of Employee Stock Option Scheme under SEBI (Share Based Employee Benefits) Regulations, 2014.
6. Convening of Extraordinary General Meeting of the Members.
Further, TRADING WINDOW for dealing in the securities of the Company will be closed from May 12, 2015 to May 24, 2015 (both days inclusive). Trading window will be opened from May 25, 2015. |
|
|